Amniotic Membrane Transplantation for Corneal Ulcers
Author Information
Author(s): Anna Carolina Badotti Linhares, Ana Caroline Martinelli, Mariela Regina Dalmarco Ghem, Paula Basso Dias, Daniel Wasilewski
Primary Institution: Hospital de ClĂnicas da Universidade Federal do Paraná
Hypothesis
To evaluate the clinical results of cryopreserved amniotic membrane transplantation as a treatment option for refractory neurotrophic corneal ulcers.
Conclusion
Cryopreserved amniotic membrane transplantation can be considered a good alternative for treating refractory neurotrophic corneal ulcers, resulting in significant improvement in pain and complete epithelial closure in many patients.
Supporting Evidence
- Approximately one-third of the patients were chronically using hypotensive eye drops.
- 90% of the patients had worse than 20/400 visual acuity preoperatively.
- 66% of patients reported total symptom relief after the surgical procedure.
- 54.6% of the patients presented a closure of epithelial defect one month after surgery.
- 45.5% of the cases had a failure rate.
Takeaway
Doctors used a special membrane from the placenta to help heal serious eye problems in 11 patients, and many felt better after the treatment.
Methodology
This prospective study included 11 eyes of 11 patients who underwent amniotic membrane transplantation for the treatment of refractory neurotrophic corneal ulcers.
Limitations
The high failure rate highlights the need for further studies to identify patient- and ulcer-related factors that may influence outcomes.
Participant Demographics
The median age of the patients was 60 years (range, 34-82 years), and 64% were men.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website